Austrian Biotech Database

Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry
Results 1 - 20 out of 76 displayed.
1 2 3 4 »

Sanofi Chief Executive Officer Olivier Brandicourt attended the China Development Forum and spoke at the Economic Summit

BEIJING, March 24, 2019 /PRNewswire/ -- Sanofi Chief Executive Officer Olivier Brandicourt expressed yesterday that he is very glad to be able to participate in the 2019 edition of the China Development Forum, particularly as it marks the 20(th) anniversary of the Forum.

Read more ››

By: PR Newswire Association LLC. - 24 Mar 2019

Sanofi: FDA issues Complete Response Letter for Zynquista(TM) (sotagliflozin)

Read more ››

By: Nasdaq / GlobenewsWire - 22 Mar 2019

Resolutions from the Annual General Meeting of Novo Nordisk A/S

Read more ››

By: Nasdaq / GlobenewsWire - 21 Mar 2019

Novo Nordisk files oral semaglutide for US regulatory approval of glycaemic control, as well as for CV risk reduction for oral semaglutide and Ozempic®

Read more ››

By: Nasdaq / GlobenewsWire - 20 Mar 2019

Novo Nordisk A/S - Share repurchase programme

Read more ››

By: Nasdaq / GlobenewsWire - 18 Mar 2019

Novo Nordisk settles US patent litigation case on Victoza® (liraglutide) with Teva

Read more ››

By: Nasdaq / GlobenewsWire - 18 Mar 2019

Praluent® (alirocumab) now approved in European Union to reduce the risk of cardiovascular events in patients with established cardiovascular disease

Read more ››

By: Nasdaq / GlobenewsWire - 16 Mar 2019

Sanofi successfully prices EUR 2 billion of bond issues

Read more ››

By: Nasdaq / GlobenewsWire - 13 Mar 2019

Novo Nordisk A/S - Share repurchase programme

Read more ››

By: Nasdaq / GlobenewsWire - 11 Mar 2019

Sanofi: FDA to undertake priority review of Dupixent® (dupilumab) for adults with inadequately controlled severe chronic rhinosinusitis with nasal polyps

Read more ››

By: Nasdaq / GlobenewsWire - 08 Mar 2019

TESARO Announces Data Presentations at the 2019 SGO Annual Meeting on Women’s Cancer

Read more ››

By: Nasdaq / GlobenewsWire - 05 Mar 2019

Novo Nordisk Pharma Ltd. partners with Health2Sync in Japan, bringing digital diabetes management to healthcare providers and patients

TAIPEI, Taiwan and TOKYO, March 5, 2019 /PRNewswire/ -- Health2Sync and Novo Nordisk Pharma Ltd. are partnering in Japan to support digital diabetes management and facilitate communication between diabetics and healthcare providers. Last December, the two companies agreed to support the localization... Read more ››

By: PR Newswire Association LLC. - 05 Mar 2019

Novo Nordisk A/S - Share repurchase programme

Read more ››

By: Nasdaq / GlobenewsWire - 04 Mar 2019

Sanofi : CHMP recommends ZynquistaTM (sotagliflozin) for the treatment of adults with type 1 diabetes

Read more ››

By: Nasdaq / GlobenewsWire - 01 Mar 2019

Sanofi: CHMP recommends approval of Dupixent® (dupilumab) for asthma indication

Read more ››

By: Nasdaq / GlobenewsWire - 01 Mar 2019

Pius S. Hornstein, PhD, Appointed New Country Chair of Sanofi China

SHANGHAI, March 1, 2019 /PRNewswire/ -- Sanofi announced that Pius S. Hornstein, PhD, has been appointed the new General Manager China, China & Emerging Markets Global Business Unit (GBU) of Sanofi and Country Chair of Sanofi China, effective today. Based in Shanghai, he reports directly... Read more ››

By: PR Newswire Association LLC. - 01 Mar 2019

Lexogen Launches CORALL - The New Stranded Whole Transcriptome Library Prep Kit for Illumina®

VIENNA, Feb. 28, 2019 /PRNewswire/ -- Today Lexogen announced the launch of the CORALL Total RNA-Seq Library Prep Kit. This new all-in-one library prep kit can be used for all whole transcriptome analysis applications such as differential expression, isoform quantification, single nucleotide... Read more ››

By: PR Newswire Association LLC. - 01 Mar 2019

Related companies: LEXOGEN GMBH

Novo Nordisk A/S - Share repurchase programme

Read more ››

By: Nasdaq / GlobenewsWire - 25 Feb 2019

Sanofi: Positive results presented from two Phase 3 trials of Dupixent® (dupilumab) in severe chronic rhinosinusitis with nasal polyps

Read more ››

By: Nasdaq / GlobenewsWire - 25 Feb 2019

Sanofi : Sanofi and Regeneron strongly disagree with verdict upholding three of five Amgen U.S. patent claims relating to PCSK9 antibodies

Read more ››

By: Nasdaq / GlobenewsWire - 25 Feb 2019

Looking for companies outside of Austria?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

March 2019
- Vienna: RESI Vienna 2019
- Vienna: BIO-Europe Spring 2019
April 2019
- Zurich: The Pharma Business Development Course

Add an Event »

Latest company news

Sanofi Chief Executive Officer Olivier Brandicourt attended the China Development Forum and spoke at the Economic Summit
24 Mar 2019 (PR Newswire Association LLC.)

Sanofi: FDA issues Complete Response Letter for Zynquista(TM) (sotagliflozin)
22 Mar 2019 (Nasdaq / GlobenewsWire)

Resolutions from the Annual General Meeting of Novo Nordisk A/S
21 Mar 2019 (Nasdaq / GlobenewsWire)

Biotechgate database

About Biotechgate
The Austrian Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com